Position in ABSI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$150,000
+$150,000 QoQ
Shares Held
50,000
Ownership
0.029%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Derivatives in ABSI
reported options exposure · as of Mar 31, 2026CallValue
$938,100
CallShares
312,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $32,694,585 across 26 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
225,000 | $15,896,250 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
50,102 | $6,650,038 | |
| 3 | MANE |
Veradermics, Inc
|
25,817 | $3,173,941 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
5,107 | $956,438 | |
| 5 | CYTK |
Cytokinetics Inc
|
9,643 | $821,487 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
21,800 | $812,486 | |
| 7 | ERAS |
Erasca, Inc.
|
34,251 | $627,478 | |
| 8 | ABVX |
Abivax S.A.
|
4,512 | $601,269 |
All Filings in ABSI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $938,100 | 312,700 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $150,000 | 50,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,091,323 | 312,700 | Call | Sole | 2026-02-13 | |
| 2024-12-31 | $52,400 | 20,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||